MONITORING OF HUMAN CYTOMEGALOVIRUS INFECTIONS AND GANCICLOVIR TREATMENT IN HEART-TRANSPLANT RECIPIENTS BY DETERMINATION OF VIREMIA, ANTIGENEMIA, AND DNAEMIA

被引:284
作者
GERNA, G [1 ]
ZIPETO, D [1 ]
PAREA, M [1 ]
REVELLO, MG [1 ]
SILINI, E [1 ]
PERCIVALLE, E [1 ]
ZAVATTONI, M [1 ]
GROSSI, P [1 ]
MILANESI, G [1 ]
机构
[1] CNR,IST GENET BIOCHIM & EVOLUZIONIST,PAVIA,ITALY
关键词
D O I
10.1093/infdis/164.3.488
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fourteen heart transplant recipients were monitored for human cytomegalovirus (HCMV) infection based on determination of antigenemia, viremia, and DNAemia (by polymerase chain reaction [PCR]) in peripheral blood polymorphonuclear leukocytes (PMNL). Three patients had symptomatic primary, 10 had recurrent (3 asymptomatic), and 1 (seronegative) had no HCMV infection. Severe clinical symptoms appeared when levels of viremia/antigenemia were > 50 infected PMNL/2 x 10(5) cells examined. Of 200 blood samples examined, 93 (46.5%) were positive for viremia/antigenemia and DNAemia, whereas 48 (24.0%) were positive for DNAemia only; 59 (29.5%) were negative in all assays. Follow-up of HCMV infections in heart transplant recipients showed that PCR can detect viral appearance in blood 7-10 days earlier than assays for antigenemia/viremia. On the other hand, viral disappearance from blood, as assessed by PCR, occurred weeks or months later than revealed by other assays. Detection of virus by PCR only was never associated with overt HCMV-related clinical symptoms. Of the 8 symptomatic patients treated with ganciclovir, 2 became PCR-negative at the end of treatment and 1 cleared virus from blood in the following weeks, whereas 5 showed persistent or recurrent infection.
引用
收藏
页码:488 / 498
页数:11
相关论文
共 38 条
[1]   THE STRUCTURE OF THE MAJOR IMMEDIATE EARLY GENE OF HUMAN CYTOMEGALO-VIRUS STRAIN AD169 [J].
AKRIGG, A ;
WILKINSON, GWG ;
ORAM, JD .
VIRUS RESEARCH, 1985, 2 (02) :107-121
[2]   PRIMER-MEDIATED ENZYMATIC AMPLIFICATION OF CYTOMEGALO-VIRUS (CMV) DNA - APPLICATION TO THE EARLY DIAGNOSIS OF CMV INFECTION IN MARROW TRANSPLANT RECIPIENTS [J].
CASSOL, SA ;
POON, MC ;
PAL, R ;
NAYLOR, MJ ;
CULVERJAMES, J ;
BOWEN, TJ ;
RUSSELL, JA ;
KRAWETZ, SA ;
PON, RT ;
HOAR, DI .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1109-1115
[3]   LOCALIZATION OF HUMAN CYTOMEGALOVIRUS IN PERIPHERAL-BLOOD LEUKOCYTES BY INSITU HYBRIDIZATION [J].
DANKNER, WM ;
MCCUTCHAN, JA ;
RICHMAN, DD ;
HIRATA, K ;
SPECTOR, SA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) :31-36
[4]   MORBIDITY OF CYTOMEGALO-VIRUS INFECTION IN RECIPIENTS OF HEART OR HEART-LUNG TRANSPLANTS WHO RECEIVED CYCLOSPORINE [J].
DUMMER, JS ;
WHITE, LT ;
HO, M ;
GRIFFITH, BP ;
HARDESTY, RL ;
BAHNSON, HT .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1182-1191
[5]   GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS [J].
ERICE, A ;
JORDAN, C ;
CHACE, BA ;
FLETCHER, C ;
CHINNOCK, BJ ;
BALFOUR, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22) :3082-3087
[6]   PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS [J].
ERICE, A ;
CHOU, S ;
BIRON, KK ;
STANAT, SC ;
BALFOUR, HH ;
JORDAN, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :289-293
[7]   IMMUNOPEROXIDASE TECHNIQUE FOR RAPID HUMAN CYTOMEGALOVIRUS IDENTIFICATION [J].
GERNA, G ;
VASQUEZ, A ;
MCCLOUD, CJ ;
CHAMBERS, RW .
ARCHIVES OF VIROLOGY, 1976, 50 (04) :311-321
[8]   HUMAN CYTOMEGALOVIRUS VIREMIA IN HIV-1-SEROPOSITIVE PATIENTS AT VARIOUS CLINICAL STAGES OF INFECTION [J].
GERNA, G ;
PAREA, M ;
PERCIVALLE, E ;
ZIPETO, D ;
SILINI, E ;
BARBARINI, G ;
MILANESI, G .
AIDS, 1990, 4 (10) :1027-1031
[9]   A 6-HOUR MICRONEUTRALIZATION ASSAY FOR HUMAN CYTOMEGALOVIRUS ANTIBODY BY USING MONOCLONAL-ANTIBODIES [J].
GERNA, G ;
REVELLO, MG ;
PERCIVALLE, E ;
TORSELLINI, M .
SERODIAGNOSIS AND IMMUNOTHERAPY IN INFECTIOUS DISEASE, 1990, 4 (03) :243-247
[10]  
GERNA G, 1990, J CLIN MICROBIOL, V25, P1548